The therapeutic age of the neonatal Fc receptor
IgGs are essential soluble components of the adaptive immune response that evolved to
protect the body from infection. Compared with other immunoglobulins, the role of IgGs is …
protect the body from infection. Compared with other immunoglobulins, the role of IgGs is …
A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
Systemic diseases and the cornea
R Shah, C Amador, K Tormanen, S Ghiam… - Experimental eye …, 2021 - Elsevier
There is a number of systemic diseases affecting the cornea. These include endocrine
disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections …
disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections …
A practical approach to the management of cerebral amyloid angiopathy
Cerebral amyloid angiopathy is a common small vessel disease in the elderly involving
vascular amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of …
vascular amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of …
The pathophysiology of the antiphospholipid syndrome: a perspective from the blood coagulation system
R Arreola-Diaz, A Majluf-Cruz… - Clinical and Applied …, 2022 - journals.sagepub.com
The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a
hypercoagulability associated to vascular thrombosis and/or obstetric morbidity, is caused …
hypercoagulability associated to vascular thrombosis and/or obstetric morbidity, is caused …
Metabolic syndrome, autoimmunity and rheumatic diseases
G Medina, O Vera-Lastra, AL Peralta-Amaro… - Pharmacological …, 2018 - Elsevier
Metabolic syndrome (MetS) is a cluster of metabolic and cardiovascular (CV) risk factors
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …
Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A …
Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …
Thrombocytopenia in pregnancy: Diagnosis and approach to management
AM Pishko, LD Levine, DB Cines - Blood reviews, 2020 - Elsevier
Thrombocytopenia during pregnancy presents unique challenges for the hematologist.
Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the …
Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the …
An update on the biologics for the treatment of antiphospholipid syndrome
Z Yun, L Duan, X Liu, Q Cai, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid …
thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid …
Hyperthrombotic milieu in COVID-19 patients
MH Kamel, W Yin, C Zavaro, JM Francis, VC Chitalia - Cells, 2020 - mdpi.com
COVID-19 infection has protean systemic manifestations. Experience from previous
coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of …
coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of …